IL34 and breast cancer: Upon binding of its ligands: CSF-1 or IL-34, dimerization and activation of CSF1R consequently catalyzes the transfer of ATP phosphate to its tyrosine residue44,63, thus triggers breast cancer cell proliferation22,25, metastasis23,31, and angiogenesis19 pathways.